Steven P Sedlis
Overview
Explore the profile of Steven P Sedlis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
909
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Smilowitz N, Carey E, Shah B, Hartigan P, Plomondon M, Maron D, et al.
Am J Cardiol
. 2022 Aug;
180:1-9.
PMID: 35918234
Randomized clinical trials have not demonstrated a survival benefit with percutaneous coronary intervention in stable ischemic heart disease (SIHD). We evaluated the generalizability of the COURAGE (Clinical Outcomes Utilizing Revascularization...
2.
Owlia M, Dodson J, King J, Derington C, Herrick J, Sedlis S, et al.
J Am Heart Assoc
. 2019 Aug;
8(15):e012811.
PMID: 31362569
Background Canadian Cardiovascular Society (CCS) angina severity classification is associated with mortality, myocardial infarction, and coronary revascularization in clinical trial and registry data. The objective of this study was to...
3.
Maron D, Mancini G, Hartigan P, Spertus J, Sedlis S, Kostuk W, et al.
J Am Coll Cardiol
. 2018 Nov;
72(19):2297-2305.
PMID: 30384885
Background: Individual risk factor control improves survival in patients with stable ischemic heart disease (SIHD). It is uncertain if multiple risk factor control further extends survival. Objectives: This study determined...
4.
Smilowitz N, Subramanyam P, Gianos E, Reynolds H, Shah B, Sedlis S
Coron Artery Dis
. 2017 Jul;
29(1):46-52.
PMID: 28746145
Background: Type 2 myocardial infarction (MI) is defined by a rise and fall of cardiac biomarkers and evidence of ischemia without unstable coronary artery disease (CAD) because of a mismatch...
5.
Sedlis S, Lorin J
JACC Cardiovasc Interv
. 2017 May;
10(10):996-998.
PMID: 28456701
No abstract available.
6.
Ujueta F, Weiss E, Shah B, Sedlis S
Curr Cardiol Rep
. 2017 Feb;
19(2):17.
PMID: 28213668
Purpose Of Review: This study aims to determine if percutaneous coronary intervention (PCI) does improve survival in stable ischemic heart disease (SIHD). Recent Findings: The International Study of Comparative Health...
7.
Teperman J, Carruthers D, Guo Y, Barnett M, Harris A, Sedlis S, et al.
Int J Cardiol
. 2016 Nov;
228:201-204.
PMID: 27865186
Background: The aim of this study was to determine the association between neutrophil-lymphocyte ratio (NLR) and severity of lower extremity peripheral artery disease (PAD). Methods: A retrospective chart review identified...
8.
Chang K, Yokose C, Tenner C, Oh C, Donnino R, Choy-Shan A, et al.
Am J Med
. 2016 Oct;
130(2):230.e1-230.e8.
PMID: 27720853
Background: An independent association between gout and coronary artery disease is well established. The relationship between gout and valvular heart disease, however, is unclear. The aim of this study was...
9.
Buntaine A, Shah B, Lorin J, Sedlis S
Curr Cardiol Rep
. 2016 Jun;
18(8):79.
PMID: 27339854
Patients with diabetes mellitus (DM) have more severe CAD and higher mortality in acute coronary syndrome (ACS) than patients without DM. The optimal mode of revascularization-coronary artery bypass grafting (CABG)...
10.
Smilowitz N, Weiss M, Mauricio R, Mahajan A, Dugan K, Devanabanda A, et al.
Int J Cardiol
. 2016 May;
218:196-201.
PMID: 27236114
Background: Type 2 myocardial infarction (MI) is defined as myocardial necrosis (myonecrosis) due to an imbalance in supply and demand with clinical evidence of ischemia. Some clinical scenarios of supply-demand...